
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11364021
[patent_doc_number] => 20170002002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'FUSED AMINO PYRIDINE AS HSP90 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/200232
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45608
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15200232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/200232 | Fused amino pyridine as HSP90 inhibitors | Jun 30, 2016 | Issued |
Array
(
[id] => 12884779
[patent_doc_number] => 20180186768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Antibacterial Compounds
[patent_app_type] => utility
[patent_app_number] => 15/736375
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736375 | Antibacterial compounds | Jun 30, 2016 | Issued |
Array
(
[id] => 11107548
[patent_doc_number] => 20160304518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 15/196262
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 64622
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15196262
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/196262 | Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators | Jun 28, 2016 | Issued |
Array
(
[id] => 13536491
[patent_doc_number] => 20180319789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => PESTICIDALLY ACTIVE TETRACYCLIC DERIVATIVES WITH SULFUR CONTAINING
SUBSTITUENTS
[patent_app_type] => utility
[patent_app_number] => 15/732804
[patent_app_country] => US
[patent_app_date] => 2016-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 409
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15732804
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/732804 | Pesticidally active tetracyclic derivatives with sulfur containing substituents | Jun 26, 2016 | Issued |
Array
(
[id] => 11908195
[patent_doc_number] => 09776999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-03
[patent_title] => 'Antiparisitic dihydroazole compounds and compositions comprising same'
[patent_app_type] => utility
[patent_app_number] => 15/191163
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38879
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/191163 | Antiparisitic dihydroazole compounds and compositions comprising same | Jun 22, 2016 | Issued |
Array
(
[id] => 12831676
[patent_doc_number] => 20180169064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => AZIRIDINE CONTAINING DNA ALKYLATING AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/736285
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736285 | AZIRIDINE CONTAINING DNA ALKYLATING AGENTS | Jun 22, 2016 | Abandoned |
Array
(
[id] => 13793259
[patent_doc_number] => 20190010168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHOD FOR THE SYNTHESIS OF RAPAMYCIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 15/737861
[patent_app_country] => US
[patent_app_date] => 2016-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737861 | Method for the synthesis of rapamycin derivatives | Jun 21, 2016 | Issued |
Array
(
[id] => 11894007
[patent_doc_number] => 09763927
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 15/184553
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17997
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15184553
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/184553 | Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof | Jun 15, 2016 | Issued |
Array
(
[id] => 11737047
[patent_doc_number] => 09701622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Antibacterial agents'
[patent_app_type] => utility
[patent_app_number] => 15/179751
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21607
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15179751
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/179751 | Antibacterial agents | Jun 9, 2016 | Issued |
Array
(
[id] => 12037635
[patent_doc_number] => 09815853
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Bridged bicyclic kallikrein inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/177641
[patent_app_country] => US
[patent_app_date] => 2016-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116438
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15177641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/177641 | Bridged bicyclic kallikrein inhibitors | Jun 8, 2016 | Issued |
Array
(
[id] => 11067608
[patent_doc_number] => 20160264572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'SUBSTITUTED PYRAZOLO[1,5-A] PYRIDINE AS TROPOMYOSIN RECEPTOR KINASE (TRK) INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/164430
[patent_app_country] => US
[patent_app_date] => 2016-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34549
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15164430
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/164430 | Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors | May 24, 2016 | Issued |
Array
(
[id] => 11066128
[patent_doc_number] => 20160263090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'ANTI-FIBROTIC PYRIDINONES'
[patent_app_type] => utility
[patent_app_number] => 15/162214
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107241
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162214 | Anti-fibrotic pyridinones | May 22, 2016 | Issued |
Array
(
[id] => 11129197
[patent_doc_number] => 20160326170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/162384
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60411
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162384
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162384 | Substituted 6,5-fused bicyclic heteroaryl compounds | May 22, 2016 | Issued |
Array
(
[id] => 11290429
[patent_doc_number] => 20160340362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Process For The Preparation Of Oxymorphone Freebase'
[patent_app_type] => utility
[patent_app_number] => 15/160238
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21406
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15160238
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/160238 | Process For The Preparation Of Oxymorphone Freebase | May 19, 2016 | Abandoned |
Array
(
[id] => 12469437
[patent_doc_number] => 09988394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Oxabicycloheptane prodrugs
[patent_app_type] => utility
[patent_app_number] => 15/154304
[patent_app_country] => US
[patent_app_date] => 2016-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 30674
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 277
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154304
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/154304 | Oxabicycloheptane prodrugs | May 12, 2016 | Issued |
Array
(
[id] => 12945529
[patent_doc_number] => 09834549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => 3,3-disubstituted-(8-aza-bicyclo[3.2.1]OCT-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (b)-HSD1
[patent_app_type] => utility
[patent_app_number] => 15/154254
[patent_app_country] => US
[patent_app_date] => 2016-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24570
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15154254
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/154254 | 3,3-disubstituted-(8-aza-bicyclo[3.2.1]OCT-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (b)-HSD1 | May 12, 2016 | Issued |
Array
(
[id] => 11633940
[patent_doc_number] => 09655895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-23
[patent_title] => 'Morphinan compounds'
[patent_app_type] => utility
[patent_app_number] => 15/148568
[patent_app_country] => US
[patent_app_date] => 2016-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16483
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/148568 | Morphinan compounds | May 5, 2016 | Issued |
Array
(
[id] => 11054390
[patent_doc_number] => 20160251352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'HETEROCYCLIC COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/148276
[patent_app_country] => US
[patent_app_date] => 2016-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135574
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148276
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/148276 | HETEROCYCLIC COMPOUND | May 5, 2016 | Abandoned |
Array
(
[id] => 13675061
[patent_doc_number] => 20160376264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => QUINOLINONE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 15/139592
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/139592 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | Apr 26, 2016 | Issued |
Array
(
[id] => 11040128
[patent_doc_number] => 20160237084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'DIHYDRO-PYRROLOPYRIDINONE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/137502
[patent_app_country] => US
[patent_app_date] => 2016-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104553
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15137502
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/137502 | DIHYDRO-PYRROLOPYRIDINONE INHIBITORS | Apr 24, 2016 | Abandoned |